AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glarikot ER 250 Tablet

Prescription Icon
Prescription Required

Marketer

Glarizonto Pharma

Salt Composition

Divalproex (250mg)

Overview Glarikot ER 250 Tablet

Epileptic seizures and migraine prevention are key uses for the extended-release medication, Glarikot ER 250mg. It's also sometimes prescribed for bipolar disorder, either independently or as part of a broader treatment plan. Dosage and frequency are determined individually by your physician to optimize symptom control. Consistent daily intake, at the same time each day, is crucial, regardless of food consumption, though its full effect may not be seen for a couple of weeks. Discontinuing or missing doses should be avoided, as this can exacerbate the condition and potentially trigger seizures. Gradual cessation under medical supervision is essential. Common side effects, often mild, include nausea, vomiting, dizziness, fatigue, visual disturbances, headaches, unsteady gait, bruising, and hypothermia. Persistent or bothersome side effects warrant medical attention, and a skin rash requires immediate consultation. Prolonged use might lead to osteoporosis and increased fracture risk. Suicidal ideation is a rare but serious potential side effect; report any mood changes to your doctor promptly. Prior medical history, particularly heart, liver, or kidney disease, urinary issues, depression, or suicidal tendencies, should be disclosed before initiating treatment. Potential drug interactions are significant, so inform your physician of all current medications. Pregnancy necessitates careful consideration and discussion with your doctor before starting or stopping Glarikot ER 250mg. Alcohol consumption is strongly discouraged due to increased risk of side effects and seizures. Regular blood tests, both pre- and post-treatment, are often necessary for optimal dose adjustment.

Primary Ingredients of Glarikot ER 250 Tablet

No information provided. A rephrased version cannot be created.

Uses of Glarikot ER 250 Tablet

Managing epileptic seizures and bipolar disorder; migraine prophylaxis.

Major Benefits of Glarikot ER 250 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glarikot ER 250 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.

Common Side effects of Glarikot ER 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Glarikot ER 250 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glarikot ER 250 Tablets can be consumed with or without food, although consistent timing is recommended.

How Glarikot ER 250 Tablet works:

The anticonvulsant Glarikot ER 250 Tablet regulates seizures by reducing hyperactivity within the brain's neuronal network.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glarikot ER 250 Tablets and alcohol may result in heightened somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glarikot 250 mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Glarikot 250 mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, presenting no known harm to infants.

DrivingDrivingUNSAFE

Driving ability may be impaired by the side effects of Glarikot ER 250 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Glarikot ER 250 Tablets pose no safety concerns for individuals with renal impairment; dosage modification is unnecessary.

LiverLiverUNSAFE

Patients with liver impairment should likely abstain from Glarikot ER 250 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Glarikot ER 250 Tablet :

Should you forget a Glarikot ER 250 Tablet dose, take it promptly. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glarikot ER 250 Tablet

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Class Anticonvulsant sodium channel blockers

FAQs on Glarikot ER 250 Tablet

Always consult your doctor before discontinuing Glarikot ER 250 Tablet. Withdrawal should be gradual, under medical supervision, to avoid potential symptoms like recurring illness, irritability, anxiety, dizziness, and tremors.
Glarikot ER 250 Tablets may be used to stabilize mood in individuals experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these fluctuations.
Glarikot ER 250 Tablets may cause weight gain, potentially due to increased appetite. Manage your weight through diet and exercise. Consult your doctor if you're concerned about weight gain.
Drowsiness is a possible side effect of Glarikot ER 250 Tablet. Refrain from driving or operating machinery requiring alertness until you understand its impact on you.
Hair loss is a possible, temporary side effect of Glarikot ER 250 Tablets, often linked to dosage. Consult your doctor if this side effect concerns you or continues.
Glarikot ER 250 Tablets can cause liver damage, especially within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting, and regularly during the initial six months, particularly for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Glarikot ER 250 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Glarikot ER 250 Tablet treatment, your doctor may order blood tests, such as a complete blood count (including platelets), bleeding time, and coagulation studies, to assess bleeding risk. Liver function tests are also recommended prior to, and periodically during the first six months of, treatment, particularly for high-risk individuals or those with pre-existing liver conditions.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may test your serum amylase levels; a positive result requires immediate medication cessation.
Glarikot ER 250 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory distress (rapid breathing, shortness of breath, or chest pain). Seek immediate medical help if an overdose occurs.
Glarikot ER 250 Tablet
92
MRP 107
14% off